Anthropic Says It Will Revolutionize Biology—Some Day
In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.
Key points
- • But as Anthropic pushes further into biological discovery, it will face the same conundrum as other biotech companies: proving their worth in trials that can’t be hastened simply by adding computers.
- • Even if AI could help sort out which new drugs or targets will work in humans versus those likely to be duds, it will still take years of testing to prove their safety and efficacy.
- • And the IPO makes clear that the company believes its technology will drive revolutionary advancements.
Source: Wired AI. This is an automatic extract of an article published by another outlet, not Zebeh's own reporting. Read the original for the full story and context.
Read the original on Wired AIDistribute these verified findings, benchmarks, and insights across your network.
Have a technical question or implementation inquiry regarding this guide? Reach our team directly at info@zebeh.com.
More news
View All NewsGrok Bot: Hand Real Work to AI Teammates That Never Clock Out
Most marketing and sales teams already pay for more software than they have hours to operate. Campaign reports...
Google: Disabled Discover Clicks Were A Bug In An Experiment via @sejournal, @MattGSouthern
Rajan Patel wrote on X that disabled source clicks on Google Discover AI summaries were a bug in an experiment that...
Why the talent crisis in advertising is real and what comes next
Bradley Keefer, Chief Revenue Officer, Keen Decision Systems The advertising industry has a talent problem...
Googlebot Must Follow Redirects From Homepage To Favicon, Updated Doc Say
Google Search has just updated its favicon documentation to now specify that Googlebot must be able to follow...